Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 3Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1

Conditions

Precancerous Conditions 214Lymphoma 47Leukemia 46Multiple Myeloma 44Leukemia, Lymphocytic, Chronic, B-Cell 42Neoplasms, Plasma Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Monoclonal Gammopathy of Undetermined Significance 39Lymphoma, Non-Hodgkin 38Lymphoma, Mantle-Cell 37Lymphoma, Large-Cell, Immunoblastic 37Lymphoma, Large B-Cell, Diffuse 37Lymphoma, Follicular 37Myelodysplastic Syndromes 36Burkitt Lymphoma 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myeloid, Acute 35Hodgkin Disease 35Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 34Myeloproliferative Disorders 34Immunoglobulin Light-chain Amyloidosis 33Waldenstrom Macroglobulinemia 32Immunoblastic Lymphadenopathy 32Uterine Cervical Neoplasms 31Lymphoma, Large-Cell, Anaplastic 31Primary Myelofibrosis 30Thrombocythemia, Essential 29Leukemia, Hairy Cell 29Leukemia, Biphenotypic, Acute 29Uterine Cervical Dysplasia 28

Interventions

Patient Reported Outcome Measures 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Multiple Chronic Conditions × Other neoplasm × Clear all
NCT03874754 2025-10-14

iHBE

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
34 enrolled 16 charts
Other neoplasm

Multiple Chronic Conditions, Diabetes Mellitus, Hypertension, Neoplasms

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

University of Tennessee

Phase NA Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT04595851 2022-11-22

Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications

University of Michigan Rogel Cancer Center

Phase NA Terminated
6 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasm

Multiple Chronic Conditions, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡